You are here

  • Home
  • Archive
  • Volume 79, Issue 11
  • Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Buch et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Buch et al
Free

Authors

  1. Correspondence to Professor Costantino Pitzalis, Experimental Medicine and Rheumatology, William Harvey Research Institute, London EC1M 6BQ, UK; c.pitzalis{at}qmul.ac.uk
View Full Text

Citation

Humby F, Lewis M, Townsend MJ, et al
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Buch et al
Annals of the Rheumatic Diseases 2020;79:e141.

Publication history

  • Received June 27, 2019
  • Revised July 1, 2019
  • Accepted July 1, 2019
  • First published July 13, 2019.
Online issue publication 
May 12, 2021

Article Versions

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.